Venlafaxine

This classification denotes an antidepressant agent with the molecular formula C17H27NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GRZ5RCB1QG, chemically known as cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, (+-)- but generally known as venlafaxine, which bears US NIH Compound Identifier 5656. European Medicines Agency schedules Venlafaxine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00034MIG. The term VENLAFAXINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules venlafaxine in its Anatomical Therapeutic Chemical (ATC) Classification. VENLAFAXINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule venlafaxine under HS 29225000 and SITC 51467. As of Q4 2014, VENLAFAXINE remains the US FDA Preferred Term for this commodity. Venlafaxine bears US NLM identifiers UMLS ID C0078569 and NCI Concept Code C1278. SMILES: OC1(C(CN(C)C)c2ccc(OC)cc2)CCCCC1.